Quebec, Ontario Researchers to do Study on Treating Depression with Omega-3

Quebec, Ontario Researchers to do Study on Treating Depression with Omega-3 In a study that will finish in the fall of 2007 and will receive funding from the European company Isodisnatura, Canadian researchers are examining the effect of omega-3 from fish oil and its ability to treat major depression.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Study Finds Common Supplement Helps To Reduce Cocaine Cravings A new study funded by the National Institutes of Health (NIH) suggests that N-acetylcysteine (NAC) might act as an agent to modulate the effects of cocaine addiction. University Study Validates Patented Maitake Extract’s Superior Immunostimulating Properties Study published in the Journal of the American Nutraceutical Association compared the immunostimulating properties of two different maitake mushroom glucan extracts, one being MaitakeGold 404®, against Lentinan, a pharmaceutical which contains a standard, well-researched mushroom derived glucan. University Study Validates Patented Maitake Extract’s Superior Immunostimulating Properties Study published in the Journal of the American Nutraceutical Association compared the immunostimulating properties of two different maitake mushroom glucan extracts, one being MaitakeGold 404®, against Lentinan, a pharmaceutical which contains a standard, well-researched mushroom derived glucan. University Study Validates Patented Maitake Extract’s Superior Immunostimulating Properties Study published in the Journal of the American Nutraceutical Association compared the immunostimulating properties of two different maitake mushroom glucan extracts, one being MaitakeGold 404®, against Lentinan, a pharmaceutical which contains a standard, well-researched mushroom derived glucan. University Study Validates Patented Maitake Extract’s Superior Immunostimulating Properties Study published in the Journal of the American Nutraceutical Association compared the immunostimulating properties of two different maitake mushroom glucan extracts, one being MaitakeGold 404®, against Lentinan, a pharmaceutical which contains a standard, well-researched mushroom derived glucan. Study Affirms Bitter Orange Has No Impact on Blood Pressure Results from the double-blind, randomized, placebo-controlled, crossover study, appear in the Winter 2005 issue of Pharmacotherapy, measured the rate-corrected QT (QTc) interval and blood pressure before dosing subjects with bitter orange extract or placebo and then again at one, three, five and eight hours after dosing. Study Affirms Bitter Orange Has No Impact on Blood Pressure Results from the double-blind, randomized, placebo-controlled, crossover study, appear in the Winter 2005 issue of Pharmacotherapy, measured the rate-corrected QT (QTc) interval and blood pressure before dosing subjects with bitter orange extract or placebo and then again at one, three, five and eight hours after dosing. Study Shows Pine Tree Bark Improves Blood Circulation, Treats Venous Ulcers Double-blind, placebo-controlled study, published in the November/December 2005 issue of Angiology, investigated the healing of venous ulcers in three groups: one group received placebo tablets, another group received Pycnogenol tablets and the final group received both Pycnogenol tablets and local topical treatment of the wound with Pycnogenol powder. Study Shows Pine Tree Bark Improves Blood Circulation, Treats Venous Ulcers Double-blind, placebo-controlled study, published in the November/December 2005 issue of Angiology, investigated the healing of venous ulcers in three groups: one group received placebo tablets, another group received Pycnogenol tablets and the final group received both Pycnogenol tablets and local topical treatment of the wound with Pycnogenol powder. Study Shows Pine Tree Bark Improves Blood Circulation, Treats Venous Ulcers Double-blind, placebo-controlled study, published in the November/December 2005 issue of Angiology, investigated the healing of venous ulcers in three groups: one group received placebo tablets, another group received Pycnogenol tablets and the final group received both Pycnogenol tablets and local topical treatment of the wound with Pycnogenol powder. Study Shows Pine Tree Bark Improves Blood Circulation, Treats Venous Ulcers Double-blind, placebo-controlled study, published in the November/December 2005 issue of Angiology, investigated the healing of venous ulcers in three groups: one group received placebo tablets, another group received Pycnogenol tablets and the final group received both Pycnogenol tablets and local topical treatment of the wound with Pycnogenol powder. Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time. Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time. Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time. Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time. Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time. Biogaia Releases Results From Allergy Study Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri. Biogaia Releases Results From Allergy Study Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri. Biogaia Releases Results From Allergy Study Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri. Biogaia Releases Results From Allergy Study Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri. L-Arginine Therapy Examined in Acute Myocardial Infarction Research published in JAMA describes a study involving subjects who had had heart attacks and continued to have symptoms of heart disease, supplemented with L-arginine. L-Arginine Therapy Examined in Acute Myocardial Infarction Research published in JAMA describes a study involving subjects who had had heart attacks and continued to have symptoms of heart disease, supplemented with L-arginine. Should The Public Be Wary of Arginine Supplements Bill Sardi comments on the January 4 issue of the Journal of the American Medical Association which reported that L-arginine supplementation resulted in the deaths of six patients versus none in an un-supplemented group. Should The Public Be Wary of Arginine Supplements Bill Sardi comments on the January 4 issue of the Journal of the American Medical Association which reported that L-arginine supplementation resulted in the deaths of six patients versus none in an un-supplemented group. Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children Study published in this week’s issue of The Lancet indicates that children whose mothers were lacking in vitamin D during pregnancy grow up to have weaker bones. Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children Study published in this week’s issue of The Lancet indicates that children whose mothers were lacking in vitamin D during pregnancy grow up to have weaker bones. Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children Study published in this week’s issue of The Lancet indicates that children whose mothers were lacking in vitamin D during pregnancy grow up to have weaker bones. Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children Study published in this week’s issue of The Lancet indicates that children whose mothers were lacking in vitamin D during pregnancy grow up to have weaker bones. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. ForsLean Favorably Alters Body Composition According to Study Published in the Journal of the International Society of Sports Nutrition A study published in the December 2005 Journal of the International Society of Sports Nutrition (www.theissn.org) entitled "Effects of Coleus forskohlii extract supplementation on body composition and markers of health in sedentary overweight females" confirmed that ForsLean(R), Sabinsa Corporation's patented Coleus forskohlii extract promotes favorable changes in body composition. ForsLean Favorably Alters Body Composition According to Study Published in the Journal of the International Society of Sports Nutrition A study published in the December 2005 Journal of the International Society of Sports Nutrition (www.theissn.org) entitled "Effects of Coleus forskohlii extract supplementation on body composition and markers of health in sedentary overweight females" confirmed that ForsLean(R), Sabinsa Corporation's patented Coleus forskohlii extract promotes favorable changes in body composition. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. ImmunoLin® Improves Quality of Life in New IBS Study Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group. ImmunoLin® Improves Quality of Life in New IBS Study Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group. ImmunoLin® Improves Quality of Life in New IBS Study Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group. ImmunoLin® Improves Quality of Life in New IBS Study Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. Human Study Shows Protandim(R) Provides a Fundamentally New Approach to Antioxidant Therapy Company announces data from a human study just published in the journal, Free Radical Biology & Medicine, which indicate that Protandim(R) was able to reduce oxidative stress in men and women, by inducing the body to produce more of its own antioxidant enzymes. Human Study Shows Protandim(R) Provides a Fundamentally New Approach to Antioxidant Therapy Company announces data from a human study just published in the journal, Free Radical Biology & Medicine, which indicate that Protandim(R) was able to reduce oxidative stress in men and women, by inducing the body to produce more of its own antioxidant enzymes. Study Compares Regulation of Conventional, Homeopathic Drugs; Finds Strong Similarities A new study comparing the standards by which homeopathic medicines are regulated to conventional drugs and dietary supplements shows that homeopathic medicines undergo extensive Food and Drug Administration (FDA) pre-market evaluation that more resembles traditional pharma than dietary supplements. Study Compares Regulation of Conventional, Homeopathic Drugs; Finds Strong Similarities A new study comparing the standards by which homeopathic medicines are regulated to conventional drugs and dietary supplements shows that homeopathic medicines undergo extensive Food and Drug Administration (FDA) pre-market evaluation that more resembles traditional pharma than dietary supplements. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Research Supports Effectiveness Of Biocell Collagen II(r) In Promoting Skin Health Bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase. Research Supports Effectiveness Of Biocell Collagen II(r) In Promoting Skin Health Bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase. Research Supports Effectiveness Of Biocell Collagen II(r) In Promoting Skin Health Bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase. Research Supports Effectiveness Of Biocell Collagen II(r) In Promoting Skin Health Bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Fish-oil Supplements May Reduce Anger in Substance Abusers Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior. Fish-oil Supplements May Reduce Anger in Substance Abusers Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior. Fish-oil Supplements May Reduce Anger in Substance Abusers Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior. Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories. Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories. Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories. Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories. Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories. Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories. Health Canada Releases January 2009 Issue of CARN Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada." Health Canada Releases January 2009 Issue of CARN Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada." Health Canada Releases January 2009 Issue of CARN Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada." Health Canada Releases January 2009 Issue of CARN Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada." Health Canada Releases January 2009 Issue of CARN Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada." Health Canada Releases January 2009 Issue of CARN Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada." Health Canada Releases January 2009 Issue of CARN Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada." Health Canada Releases January 2009 Issue of CARN Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada." NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009 NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009 Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009. Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009. Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009. Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009. Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009. Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009. Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009. Natural Products Association Advocates Strength of Dietary Supplement Law The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation. Natural Products Association Advocates Strength of Dietary Supplement Law The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation. Natural Products Association Advocates Strength of Dietary Supplement Law The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation. Natural Products Association Advocates Strength of Dietary Supplement Law The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation. Natural Products Association Advocates Strength of Dietary Supplement Law The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation. Natural Products Association Advocates Strength of Dietary Supplement Law The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.	MONTREAL (CP) - Researchers from Quebec and Ontario will study the effects of omega-3 fatty acids in treating depression. "Patients need new treatments for depression," said Dr. Francois Lesperance, head of the psychiatry department at the Centre hospitalier de l'Universite de Montreal. Omega-3 fatty acids could offer an alternative treatment for those suffering from depression, he told a news conference Wednesday. Lesperance added that although antidepressants are available through prescription, they do have limitations and aren't always effective. Some participants in the study will take fish oil supplements, while others will take a placebo with sunflower oil, which is low in omega-3. The study will finish in the fall of 2007 and will receive funding from the European company Isodisnatura. Researchers from Quebec's McGill University, Laval University and the University of Montreal as well as Queen's University in Kingston, Ont., will conduct the study. Lesperance said one million Canadians suffer from depression. Omega-3 fatty acids, found in such foods as flaxseed oil, canola oil and salmon, are thought to increase HDL, the so-called good cholesterol.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software